Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16542989 | 0.86 | NAAA (0.46) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL27529753 | 0.83 | NAAA (0.43) | NAAANPSR1RAD52FAAHHTR2C | |
| SCHEMBL11438850 | 0.81 | MAPT (0.43) | NAAANPSR1MAPTRAD52DGKA | |
| SCHEMBL11237496 | 0.80 | NAAA (0.38) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL25964438 | 0.79 | DGKA (0.42) | NAAANPSR1MAPTMAPK1RAD52 | |
| SCHEMBL25964471 | 0.79 | DGKA (0.42) | NAAANPSR1MAPTMAPK1RAD52 | |
| SCHEMBL11443787 | 0.78 | MAPT (0.43) | NAAAMAPTFAAHDGKAEPHX1 | |
| SCHEMBL10451644 | 0.78 | ALDH1A1 (0.42) | NAAAMAPTMAPK1L3MBTL1EPHX1 | |
| SCHEMBL16710359 | 0.78 | ALDH1A1 (0.42) | NAAAMAPTMAPK1L3MBTL1EPHX1 | |
| SCHEMBL9016837 | 0.75 | NAAA (0.62) | NAAANPSR1MAPTMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115218-B2 | Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer | ADOCIA (FR) | 2015-08-25 | — | — | US | disclosed |
| US-20110195913-A1 | Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer | ADOCIA (FR) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195913-A1 | Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer | CD44, CSGALNACT1, ALG1 | NAAA 1091/4885NPSR1 1566/4885MAPT 3199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.